This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kite Pharma, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ruth E Winter: Innovator in Cell Therapy
Introduction
Ruth E Winter is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of cell therapy, particularly in enhancing immune cell function. Her innovative work has led to the development of a unique chimeric receptor that has the potential to improve CAR and TCR function through enhanced cytokine signaling.
Latest Patents
Ruth E Winter holds 1 patent related to immune cell function. The patent focuses on a membrane-bound interleukin 15 (IL-15)-IL-15Ralpha sushi domain chimeric receptor. This invention includes various embodiments that may comprise a FAS transmembrane domain or an IL-7 transmembrane domain. The chimeric receptor is designed with different polypeptide lengths between the IL-15 region and the transmembrane domain, showcasing her innovative approach to cell therapy.
Career Highlights
Ruth E Winter has established herself as a key figure in the biotechnology sector. She is currently associated with Kite Pharma, Inc., where she continues to advance her research in cell therapy. Her work is instrumental in developing therapies that could significantly impact cancer treatment and other immune-related conditions.
Collaborations
Ruth collaborates with various professionals in her field, including her coworker Saikat Banerjee. Their combined expertise contributes to the innovative projects at Kite Pharma, Inc., enhancing the potential for breakthroughs in cell therapy.
Conclusion
Ruth E Winter's contributions to the field of cell therapy exemplify the impact of innovative thinking in biotechnology. Her patent on the chimeric receptor represents a significant advancement in improving immune cell function. Through her work at Kite Pharma, Inc., she continues to push the boundaries of what is possible in medical science.